Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810985) titled 'Bismuth Quadruple Therapy Versus Modified Bismuth Therapy for Helicobacter Py... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811024) titled 'First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Cathet... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811128) titled 'Leveraging Digital Health Solutions to Collect Patient-Reported Outcomes in R... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811180) titled 'Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive C... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811674) titled 'Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activatio... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813130) titled 'A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosom... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813897) titled 'Efficacy of Palonosetron Plus Dexamethasone for Prevention of Postoperative N... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815197) titled 'Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer' on Sept. ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815626) titled 'Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Inj... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811063) titled 'A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729' on Sep... Read More